UNLABELLED: There is controversy in the literature regarding the association between papillary thyroid carcinoma (PTC) and Hashimoto's thyroiditis (HT) and as to what would be the etiological relationship between them. OBJECTIVE: To establish the proportion of cases among patients with TH and CPT, correlating it with histomorphological aspects. METHOD: A retrospective study of patients undergoing partial or total thyroidectomy for PTC between 2007 and 2009, a total of 41 cases. RESULTS: Regarding the association of HT and CPT, we found 11 cases (26.8%), all females, but without statistical significance. The mean age was 44.9 years among the patients with coexistent TH and CPT, whereas it was 49.1 years without that association. The average size of tumors in those without TH was 20.53 mm and for those with TH it was 12.72 mm (p = 0.4). Regarding pathology staging, the ratios between those with and those without TH were kept in T1a, T1b and T3. In T2, there were no cases of coexistence of HT and PTC. CONCLUSION: There is a rate of 26.8% of patients with association between TH and CPT, but without differences in relation to tumor size.
UNLABELLED: There is controversy in the literature regarding the association between papillary thyroid carcinoma (PTC) and Hashimoto's thyroiditis (HT) and as to what would be the etiological relationship between them. OBJECTIVE: To establish the proportion of cases among patients with TH and CPT, correlating it with histomorphological aspects. METHOD: A retrospective study of patients undergoing partial or total thyroidectomy for PTC between 2007 and 2009, a total of 41 cases. RESULTS: Regarding the association of HT and CPT, we found 11 cases (26.8%), all females, but without statistical significance. The mean age was 44.9 years among the patients with coexistent TH and CPT, whereas it was 49.1 years without that association. The average size of tumors in those without TH was 20.53 mm and for those with TH it was 12.72 mm (p = 0.4). Regarding pathology staging, the ratios between those with and those without TH were kept in T1a, T1b and T3. In T2, there were no cases of coexistence of HT and PTC. CONCLUSION: There is a rate of 26.8% of patients with association between TH and CPT, but without differences in relation to tumor size.
Authors: Cláudia M Coeli; Alexandre S Brito; Flávia S Barbosa; Michele G Ribeiro; Ana Paula A V Sieiro; Mário Vaisman Journal: Arq Bras Endocrinol Metabol Date: 2005-10-19
Authors: Dongbin Ahn; Sung Jae Heo; Ji Hyun Park; Jae Hyug Kim; Jin Ho Sohn; Ji Young Park; Sun-Kyun Park; Junesik Park Journal: Acta Oncol Date: 2011-08-28 Impact factor: 4.089
Authors: A Wirtschafter; R Schmidt; D Rosen; N Kundu; M Santoro; A Fusco; H Multhaupt; J P Atkins; M R Rosen; W M Keane; J L Rothstein Journal: Laryngoscope Date: 1997-01 Impact factor: 3.325
Authors: Daniel Repplinger; Anna Bargren; Yi-Wei Zhang; Joel T Adler; Megan Haymart; Herbert Chen Journal: J Surg Res Date: 2007-10-29 Impact factor: 2.192
Authors: Daysi Maria de Alcântara-Jones; Tania Freitas de Alcântara-Nunes; Bruno de Oliveira Rocha; Rafael Daltro de Oliveira; Allan Chastinet Pitangueira Santana; Fernanda Tavares de Alcântara; Thais Magalhães de Faria; Igor Campos da Silva; Leila Maria Batista Araújo Journal: Radiol Bras Date: 2015 May-Jun
Authors: Christina Resende de Paiva; Christian Grønhøj; Ulla Feldt-Rasmussen; Christian von Buchwald Journal: Front Oncol Date: 2017-04-10 Impact factor: 6.244